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Why Use Livestock as a Model to Understand
Anovulation and Female Infertility?

Implications
•	Anovulation is a major cause of infertility in mammalian
females.
•	Ovarian research in humans is challenging due to the shortage
of “normal tissue” that can be obtained from women that are
trying to get pregnant.
•	Livestock animals provide valuable resources to investigate
the optimal intra-follicular environment required to facilitate
folliculogenesis and translate to humans.
•	Different livestock models may be more useful depending on
the specific biological process studied.
Key words: follicles, human, infertility, livestock

Introduction
Infertility is defined as the inability to achieve pregnancy
after 1 yr of regular unprotected intercourse (Smith et al.,
2003; Adams et al., 2012). In western countries, one in seven
couples will seek medical advice for reproductive failure and
infertility affects 8% to 10% of married or cohabiting couples
(Allan et al., 1998). A major cause of infertility in mammalian
females is anovulation. Endocrine hormone imbalances due to
inappropriate regulation of the hypothalamic–pituitary–gonadal axis commonly lead to ovulatory disorders (Figure 1)
which account for 25% of couples seeking fertility treatment
(Smith et al., 2003). Understanding what affects the ovulation
process as well as understanding what might be happening with
the complex process of folliculogenesis or atresia would allow
for development of innovative strategies to improve female fertility. Moreover, a better understanding of the physiological
processes that control ovarian folliclular development and
leads to the development of a mature oocyte, within a follicle,
would allow for more optimal assisted reproductive technologies in livestock and women (Allan et al., 1998).
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Ovarian research in humans is challenged due to the
shortage of normal tissue from women of reproductive age
that has not been subjected to large doses of hormones used in
vivo for assisted reproductive protocols (Campbell et al., 2003).
Animal models that can be manipulated or used to obtain specific cells or tissues are considered valuable as tools to investigate pathophysiological processes of human diseases. Owing
to the obvious logistical and ethical limitations on human experimentation, some relevant queries cannot be answered by
directly studying affected human patients. In addition, the use
of animal models can improve our understanding of the pathophysiology of human diseases and support and test development of innovative therapies or treatments.
For decades, researchers have utilized rodents as a model
for human disease and to understand human physiology.
As an example of how much rodents are utilized as human
models, Adams et al., 2012) reported that 98% of grants
from the National Institutes of Health and the Department
of Health and Human Services utilized rodents as the model
for research. Rodents are a cost-effective model and they have
short-generation intervals. Novel technologies can be used to
genetically alter or eliminate genes in specific cells of rodents
to better understand biological processes critical to biomedical research. However, there are also limitations to the use
of rodents as biomedical models. When investigating reproductive processes such as folliculogenesis, the rodent is not as
effective a model as other species in translating to human pathologies (Paixao et al., 2017) (Table 1). For example, rodents
are considered poly-ovulatory while women are considered
mono-ovulatory. Additionally, the onset and development of
folliculogenesis is very different between rodents and women
(Adams et al., 2012) (Table 1). The rodent reproductive cycle is
also very short (i.e., 4 d) when compared with 28 d in women
(Table 1). Finally, rodents have a gestation length of 21 d compared with 9 mo in women (Table 1) and it is very difficult to
collect sufficient quantities of blood samples from rodents to
obtain dynamic patterns of endocrine, metabolic, or steroid
hormones for comparison to women (Soncin et al., 2015).
Several different domestic livestock and nonhuman primate
models are beneficial to understanding human biological processes. Pigs and humans have anatomical and physiological
similarities that make the pig a good model to study human
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diseases. Pigs are also widely used as biomedical research models
since many of their organs are of similar size and function as
human organs (Bassols et al., 2014). The digestive system in
pigs is similar to humans and obesity/nutrition-related questions can be answered in this livestock model (Pedersen et al.,
2013). The pig is a litter-bearing species with a shorter generation interval, so trans-generational questions may be answered
in shorter timeframes (Hanson and Skinner, 2016).
The sheep model provides a good resource for addressing
underlying mechanisms and developing preventative and treatment options that are likely to be of translational value to humans (Padmanabhan and Veiga-Lopez, 2013) (Table 1). The
basic anatomy, physiology, and size of sheep allows for physiological monitoring and sampling devices to be inserted during
gestation to monitor vital signs without loss of pregnancy or
undue stress. Other species such as cattle are less resilient to this
invasive monitoring during gestation and often do not maintain the pregnancy (Padmanabhan and Veiga-Lopez, 2013).
Thus, pregnant sheep have been utilized to develop inter-uterine
gestational restriction models due to their hardy nature and
ability to maintain pregnancies even when they are being used
to insert monitoring devices or obtain blood and gestational
fluids. Thus, pregnant sheep are a major model used to understand prenatal programming and events leading to parturition
(Grigsby, 2016). One major difference in the pig and sheep is
that they are poly-ovulatory and women are mono-ovulatory,
which presents challenges when trying to understand follicle
development, dominance and oocyte development (Table 1).
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Figure 1. Conceptual model of how androstenedione affects the normal hypothalamic–anterior pituitary–ovarian axis resulting in anovulation. A4, androstenedione; E2, estradiol-17β; FSH, follicle-stimulating hormone; GnRH,
gonadotropin-releasing hormone; LH, luteinizing hormone.

Monkeys have been used frequently to investigate human
diseases since they are nonhuman primates and have 90% to
93% genetic similarity to humans (Bailey, 2014). They have
similar biological processes and are excellent models to better
understand reproduction, disorders, and disease. Monkeys
also have similar gestation length and have an actual menstrual
cycle instead of an estrous cycle, and folliculogenesis in monkeys is similar to women. However, collection of tissue in monkeys at specific follicular developmental phases is difficult and
monkeys are expensive to house and maintain (Bailey, 2014).
The bovine model system is well suited to understand reproductive disorders in women. Secretion of hormones during
the reproductive (estrous) cycle in cattle is very similar to the
menstrual cycle in women and both species have multiple follicular waves that result in ovulation of a single ovarian follicle (Adams and Pierson, 1995). The size of ovarian follicle is
similar (15 to 20 mm in diameter) between species and similar
pathologic conditions can occur in both species (Adams and
Pierson, 1995) (Table 1). The period of follicle assembly (in the
developing fetus) occurs through day 133 and 142 of gestation
in humans and cattle, respectively (Table 1). Furthermore, both
species undergo this transition at a similar time point coinciding with mid-gestation (Adams et al., 2012). In humans, the
length of the ovarian luteal phase and the length of gestation
are also similar to cattle (Table 1). The cow provides an adequate amount of tissue and purified cell populations to conduct experiments, which is often difficult to obtain in women.
Cows can be maintained in large groups of genetically similar
females under consistent environmental conditions to reduce
sources of phenotypic variation. Thus, cattle are valuable
models to elucidate the endocrine and local mechanisms controlling both early and terminal stages of ovarian folliclular development in mono-ovulatory species. Experiments conducted
in the cow can have direct relevance to ovarian reproductive
disorders in women (Campbell et al., 2003).

Livestock Animals to Study Ovarian Folliclular
Development and Ovulatory Dysfunction as a
Biomedical Model for Humans
The mechanisms that underlie the regulation of
folliculogenesis are still unclear (Juengel et al., 2018) and need
extensive study to unravel major regulators that control these
processes. Folliculogenesis begins before birth and continues

Table 1. Reproductive characteristics of humans, ewes, cows, and rodents
Reproductive characteristics

Women

Cows

Ewes

Rodents

Days of gestation that follicle assembly occurs

133

142

100

Shortly after birth

Ovulatory cycle (days)

24–30

17–24

13–19

4–6

Ovulations per cycle

1

1

1–3

12–14

Length of follicular phase (days)

12–14

2–3

2–3

1–3

Length of luteal phase (days)

14–16

15–18

12–14

Depends on whether female
engages in copulation

Diameter of ovulatory follicle (mm)

18–20

15–20

5–7

0.9–1.1

Duration of gestation (days)

278–282

278–282

142–148

21
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throughout the reproductive lifespan. Ovarian follicles progress
from primordial to later stages with only a small percentage
developing to preantral and actually ovulating. A major portion
of follicles in mammalian species undergoes atresia (Fortune
et al., 2000). Since failure to ovulate (anovulation) is the largest
problem with reproduction in female mammals, animal models
that exhibit disrupted or arrested ovarian follicular development
provide valuable resources to investigate the intra-follicular environment that is required to facilitate ovarian folliculogenesis
and ovulation in humans (Campbell et al., 2003).
One disorder that displays ovarian follicular arrest and
anovulation is polycystic ovary syndrome (PCOS), a multifactorial disorder affecting 9% to 18% (Di Pietro et al., 2015)
of reproductive age women. PCOS is often diagnosed when
hyperandrogenism and infertility occur due to dysfunctional
follicular maturation and anovulation (Figure 1). The PCOS
phenotype has been shown to be programmed during fetal development (Dumesic et al., 2007) when exogenous androgens have
been administered. However, the etiology of PCOS is still poorly
understood. Thus, any information from animal models that have
similar characteristics to PCOS may help improve current understanding of the mechanisms of PCOS initiation and development.
Women with two of the three criteria are diagnosed with PCOS:
1) ovulatory dysfunction (amenorrhea or oligomenorrhea);
2) hyperandrogenism; and 3) polycystic ovaries. However, several
laboratories suggest (Abbott et al., 2002) that androgen excess is
the most important criteria in women diagnosed with PCOS and
is caused by abnormal theca cell function leading to abnormal
ovarian follicular development (Abbott et al., 2002).
A recent review (Paixao et al., 2017) identified about 933
studies using animals as models to study human diseases.
They focused on 39 studies that used different animal models
to induce PCOS-like symptoms. These 39 studies included
18 studies with androgen-induced stimulation, 9 studies with
estrogens or drugs with estrogen action, including endocrine
disruptors, and 12 studies with miscellaneous interventions
(other than androgen and estrogen treatment to induce PCOS
such as transgenic animals or specific strains). In this review,
there was a broad difference among the studies concerning
hormonal interventions, animal species, and developmental
stage at the time of the experiments. However, most of these
studies showed ovarian morphological changes, with increases in the number of cystic and antral follicles and the
absence or decrease in the number of corpus lutea suggesting
follicles were not ovulating and the animals were anovulatory. As mentioned by this review, most of these studies provide important information on physiological processes that
are altered and may contribute to anovulation in women. In
addition, these studies may help clarify the mechanisms of
anovulation in PCOS patients.

Prenatally Androgenized Animals as a Model
for PCOS
A sheep androgenized model has made significant progress
in generating new knowledge to increase our understanding
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of how gestational testosterone administration may result in
a PCOS-like phenotype. Female sheep fetuses exposed to testosterone during early to mid-gestation exhibited reproductive
defects including ovarian dysfunction and irreversible morphological and functional changes in the reproductive axis after
puberty (Forsdike et al., 2007; Steckler et al., 2009). These
individuals also had disrupted reproductive cycles and an increase in the proportion of growing follicles in the ovarian
cortex during postnatal life along with metabolic characteristics similar to PCOS when compared with nonandrogenized
fetuses (Steckler et al., 2009). These studies suggest that reproductive disruptions and PCOS-like symptoms may be caused
by exposure to prenatal testosterone excess. The results of this
study may be of relevance to understanding ovarian cycle disruption and the etiology in women with PCOS (Padmanabhan
and Veiga-Lopez, 2013).
The prenatally androgenized sheep model was used to study
ovarian steroidogenesis and follicle formation with different
breeds of sheep at day 90 (Comim et al., 2015) and 140 (Smith
et al., 2009). Results of these studies suggested that fetal exposure to testosterone may cause advanced timing of ovarian
follicle formation. Ovaries from androgenized fetuses collected at 140 d of gestation also observed increased formation
of ovarian follicles (Smith et al., 2009). Androgen receptors
were present in greater concentrations in primordial and primary follicles in ovaries at day 90 in prenatally androgenized
fetuses compared with controls, so it is possible that ovarian
follicular formation did not occur until later in fetal development. An interesting shift in steroidogenesis was also detected
in the ovaries from day 90 prenatally androgenized fetuses
with an increased proportion of ovarian follicles positive for
HSD3B2 protein compared with controls. Increased expression
of HSD3B2 suggests increased activity of the enzyme and a
shift from the delta-5 to the delta-4 pathway of steroid biosynthesis in ovaries from prenatally androgenized fetuses. These
data raise key questions about the role of exposure to androgen
in utero in developmental origins of PCOS and support the
concept that aberrant ovarian follicular development in PCOS
is programmed by exposure of the ovary to excess androgen
during fetal life.
In addition to changes in ovarian follicular development,
prenatal androgenized ovaries had changes in matrix proteins, which have been shown to contribute to development
of persistent ovarian follicles. The increase in matrix proteins
disrupts the normal tissue remodeling process, availability of
different growth factors, and communication through gap
junctions. It also causes thickening of the ovarian cortex, which
is often seen in women diagnosed with PCOS (Puttabyatappa
et al., 2018). Increases in matrix metalloproteinases may be
related to increased androgen receptor expression (Ortega
et al., 2009). Thus, prenatal androgen exposure may alter
ovarian folliculogenesis through direct androgen actions and
also actions of androgens on remodeling and structure of the
ovarian matrix. These changes in structure of the ovarian matrix may also inhibit the ability of these follicles to mature and
to ovulate resulting in the polycystic phenotype.
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Exposure to prenatal androgen also results in altered LH secretion, reduced hypothalamic sensitivity to steroid negative feedback, and increased insulin secretion due to increased abdominal
adiposity in rhesus monkeys (Dumesic et al., 2007). These monkeys had ovarian morphology similar to PCOS patients with
hypergonadotropism and polycystic ovaries. Thus, nonhuman
primates exposed to prenatal androgen recapitulate the metabolic
and reproductive traits that are often associated with PCOS.

Naturally Occurring Animal Models of
Androgen Excess
Most of the animal models for PCOS are developed
via exogenous androgen treatment (Dumesic et al., 2007;
Forsdike et al., 2007; Steckler et al., 2009) or increases in diet
(Newell-Fugate et al., 2014). There are several animal models
that have naturally occurring androgen excess and similar
characteristics to women with PCOS. Naturally occurring
hyperandrogenism has been described in adult female
monkeys with elevated LH and anti-Mullerian hormone,
anovulation, poly-follicular ovaries, and infertility (Abbott
et al., 2017). Scientists that have identified this population
of monkeys do not know whether these hyperandrogenic individuals are present in all monkey populations or the percentage of the population that are affected in most monkey
colonies.
An additional naturally occurring androgen excess
animal model with PCOS-like characteristics is the High

A4 cow model described by Summers et al. (2014). These
scientists identified a subpopulation of beef cows that contain excess intrafollicular androstenedione (A4), theca molecular phenotypes (greater mRNA abundance CYP17A1,
CYP11A1, GATA6, and LHCGR) similar to women diagnosed with PCOS and subfertility, with a 17% reduced
calving rate (Summers et al., 2014). Interestingly, these High
A4 cows have offspring that are 24 kg heavier at weaning
(Summers et al., 2014). Cattle producers often maintain females in the herd that wean heavier calves to increase their
profitability by selling more pounds of product. Thus, the
High A4 phenotype may have been a result of retaining
these females in the herd with heavier weaned calves and
selecting for growth over reproduction traits. Investigation
of the muscle tissue of these High A4 cows indicates that
their myoblasts are not proliferating but are differentiated
and may be in cell cycle arrest. The fact that High A4 cows
have calves with heavier weaning weights may suggest that
the in utero environment the fetus is subjected to inhibits
growth of the fetus in utero (through prenatal programming)
and there is compensatory growth from birth to weaning,
which is similar to the in utero model of women with PCOS
(Barnes et al., 2018).
In High A4 cows, the excess androgen appeared to be
coming from the ovarian theca cells since mRNA abundance for CYP11A1 and CYP17A1 (Figure 2) was increased along with mRNA abundance for a transcription
factor GATA6, which upregulated promoter regions of

LH

cAMP
PKA
Pregnenolone
CYP11
(21C)
CYP17
(OH-ase)

Androstenedione
(19C)

Cholesterol
(27C)

17-OH Pregnenolone
(21
(21C)
D
DHEA
(19C)

Theca Cell
Figure 2. Conceptual model of the normal hormonal steroidogenic pathway in theca cells of the bovine ovary. Cows with excess androstenedione (High A4)
have increased expression of several gene (e.g., CYP11A1 and CYP17A1) in the steroidogenic pathway.
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Figure 3. Stages of ovarian follicular development in bovine ovaries. Normal ovarian follicles develop from primordial follicles to primary follicles to secondary
follicles to antral follicles, which may ovulate. In cows with excess androstenedione (High A4), secondary ovarian follicles do not develop to the antral follicle
stage; thus, ovulation is blocked.

both of these steroidogenic enzymes (Summers et al.,
2014). In addition to these genes, there was also increased
mRNA abundance of LHCGR receptor (Summers et al.,
2014) (Figure 2). In theca cell lines derived from women
diagnosed with PCOS, microarray data demonstrated increases in CYP11A1, CYP17A1, GATA6, and LHCGR receptor (Wood et al., 2004). In addition, the maternal effect
gene ZAR1 was altered in oocytes from High A4 cows when
compared with controls in a manner similar to that seen in
women with PCOS (Summers et al., 2014) suggesting potential effects on oocyte competence and fertility. Thus, this
naturally occurring androgen excess High A4 cow model
has a very similar theca and oocyte molecular phenotype
to women diagnosed with PCOS and can be used to understand aspects of androgen excess.
Arrest of ovarian follicles was also a characteristic of this
High A4 population of cows where there were reduced numbers
of tertiary follicles per section, suggesting arrest of ovarian
follicles at the antral stage (Summers et al., 2014) (Figure 3).
In addition to increases in A4 in ovarian follicular fluid,
there were also increases in testosterone, estrogen, DHEA,
11-deoxycortocosterone, and 11-deoxycortisol, suggesting
that steroidogenesis is using the delta-5 pathway normally
seen to be upregulated in PCOS patients (Rosencrantz et al.,
2011). The High A4 population of cows has been identified
in other herds; thus, this model may be more widespread
than previously described (Summers et al., 2014). It also appears that the High A4 population cows may constitute 15%
to 20% of the herd. Thus, this High A4, natural occurring androgen excess model in beef cattle, could further our understanding of PCOS and provide potential treatment options
in the future.

Conclusions
Domestic livestock have tremendous benefits to provide
avenues to conduct biomedical research. These domestic livestock models should be pursued and exploited to provide strategies to increase translation of biomedical research to human
diseases. Many diseases and disorders are similar in domestic
livestock and humans and with the appropriate approach could
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be synergistically tested to increase efficiency of application of
new knowledge and potential therapies.
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